BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9020845)

  • 41. Molecular and genomic characterisation of cryptic chromosomal alterations leading to paternal duplication of the 11p15.5 Beckwith-Wiedemann region.
    Russo S; Finelli P; Recalcati MP; Ferraiuolo S; Cogliati F; Dalla Bernardina B; Tibiletti MG; Agosti M; Sala M; Bonati MT; Larizza L
    J Med Genet; 2006 Aug; 43(8):e39. PubMed ID: 16882733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
    Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
    Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.
    Matsuoka S; Thompson JS; Edwards MC; Bartletta JM; Grundy P; Kalikin LM; Harper JW; Elledge SJ; Feinberg AP
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3026-30. PubMed ID: 8610162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beckwith-Wiedemann syndrome.
    Choufani S; Shuman C; Weksberg R
    Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):343-54. PubMed ID: 20803657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.
    Splawski I; Shen J; Timothy KW; Vincent GM; Lehmann MH; Keating MT
    Genomics; 1998 Jul; 51(1):86-97. PubMed ID: 9693036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region.
    Reid LH; Davies C; Cooper PR; Crider-Miller SJ; Sait SN; Nowak NJ; Evans G; Stanbridge EJ; deJong P; Shows TB; Weissman BE; Higgins MJ
    Genomics; 1997 Aug; 43(3):366-75. PubMed ID: 9268640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome.
    Horike S; Mitsuya K; Meguro M; Kotobuki N; Kashiwagi A; Notsu T; Schulz TC; Shirayoshi Y; Oshimura M
    Hum Mol Genet; 2000 Sep; 9(14):2075-83. PubMed ID: 10958646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region.
    Rossignol S; Steunou V; Chalas C; Kerjean A; Rigolet M; Viegas-Pequignot E; Jouannet P; Le Bouc Y; Gicquel C
    J Med Genet; 2006 Dec; 43(12):902-7. PubMed ID: 16825435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
    Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
    Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beck-Wiedemann syndrome and Wilms' tumour.
    Ward A
    Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: implications for hemihyperplasia, associated neoplasms, and overgrowth.
    Cohen MM
    Am J Med Genet; 1994 Aug; 52(2):233-4. PubMed ID: 7802016
    [No Abstract]   [Full Text] [Related]  

  • 52. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
    Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
    Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth regulation, imprinted genes, and chromosome 11p15.5.
    Smith AC; Choufani S; Ferreira JC; Weksberg R
    Pediatr Res; 2007 May; 61(5 Pt 2):43R-47R. PubMed ID: 17413842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer.
    Tanaka K; Shiota G; Meguro M; Mitsuya K; Oshimura M; Kawasaki H
    Oncology; 2001; 60(3):268-73. PubMed ID: 11340379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development.
    Weksberg R; Smith AC; Squire J; Sadowski P
    Hum Mol Genet; 2003 Apr; 12 Spec No 1():R61-8. PubMed ID: 12668598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction.
    Feinberg AP
    Cancer Res; 1999 Apr; 59(7 Suppl):1743s-1746s. PubMed ID: 10197590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
    Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice.
    Lee MP; Ravenel JD; Hu RJ; Lustig LR; Tomaselli G; Berger RD; Brandenburg SA; Litzi TJ; Bunton TE; Limb C; Francis H; Gorelikow M; Gu H; Washington K; Argani P; Goldenring JR; Coffey RJ; Feinberg AP
    J Clin Invest; 2000 Dec; 106(12):1447-55. PubMed ID: 11120752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beckwith-Wiedemann syndrome.
    Weksberg R; Shuman C; Smith AC
    Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):12-23. PubMed ID: 16010676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
    Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
    Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.